Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products (Q45868913)

17 December 2017

title

Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products (English)

1 reference

17 December 2017

author name string

Yuasa K

1

1 reference

17 December 2017

Yoshimura M

2

1 reference

17 December 2017

Urasawa N

3

1 reference

17 December 2017

Ohshima S

4

1 reference

17 December 2017

Howell JM

5

1 reference

17 December 2017

Nakamura A

6

1 reference

17 December 2017

Hijikata T

7

1 reference

17 December 2017

Miyagoe-Suzuki Y

8

1 reference

17 December 2017

Takeda S

9

1 reference

17 December 2017

publication date

21 June 2007

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

issue

17

1 reference

17 December 2017

page(s)

1249-1260

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302984

exact match

0 references

cites work

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Canine X-linked muscular dystrophy in Japan (CXMDJ)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Canine X-linked muscular dystrophy: morphologic lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Use of the dog model for Duchenne muscular dystrophy in gene therapy trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302984

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302984

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017